MIR5697

Across TCGA pan-cancer cohorts, MIR5697 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR5697 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR5697 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR5697 expression acts as an unfavorable survival marker, although some lineages such as TGCT and STAD show a favorable association.

ACC, MESO, and READ are the cancer types where MIR5697 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	II,III,IV	0.039	0.595	<.001	66	view →
MESO	DFS	Tertile	All	0.124	0.483	.016	45	view →
READ	OS	Tertile	III,IV	0.220	0.912	<.001	42	view →
THYM	OS	Tertile	All	0.820	0.984	<.001	39	view →
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	36	view →
LGG	DFS	Tertile	All	0.281	0.425	<.001	36	view →
CHOL	DFS	Tertile	II,III,IV	0.139	0.543	.012	33	view →
BRCA	OS	Tertile	All	0.473	0.617	.011	28	view →
KICH	OS	Tertile	III,IV	0.153	0.755	.028	18	view →
PAAD	DFS	Tertile	All	0.297	0.491	.032	18	view →
PCPG	OS	Tertile	All	0.909	0.985	.020	15	view →
SKCM	OS	Tertile	IV	0.142	0.567	.016	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MIR5697–ACC (DFS)

Open the ACC breakdown →